DCC Revolutionizing Drug Regulation: Central Drug Regulator Advances Towards a Digital Era

WhatsApp D. Pharma Group Join Now
Telegram D. Pharma Group Join Now
Telegram Group Latest Pharma Jobs Join Now
Telegram B. Pharma Group Join Now
Telegram Medicine Update Group Join Now
WhatsApp B. Pharma/ GPAT Channel Join Now

In a significant stride towards transparency and corruption prevention in drug regulation, the central drug regulator is gearing up to introduce a digital platform. The recent Drugs Consultative Committee (DCC) meeting, chaired by the Drugs Controller General (India) Dr Rajeev Singh Raghuvanshi, highlighted the imperative need for Standard Operating Procedures (SOPs) for videography in procedures related to sampling and testing.


The DCC emphasized the creation of an SOP specifically for videography in the processes of sample receipt, seal opening, and sample distribution to analysts. To achieve this, a sub-committee is set to be formed, comprising experts from Central and state labs, the Central Drugs Standard Control Organisation (CDSCO), and a technologist with expertise in the field. Their role will be to deliberate on and provide recommendations for this innovative approach.

The committee underscored the government’s consideration of leveraging digital platforms to enhance transparency in inspection, drawing, and testing of drug samples. The key deliberation point was how digital platforms could play a pivotal role in preventing corruption and minimizing discretionary powers.

For example, the Department of Health and Family Welfare is actively working on implementing online entry of recommendations during inspections by drug inspectors. Technologies such as videography are seen as essential tools to prevent sample tampering and ensure the integrity of drug-testing processes.

Furthermore, discussions within the committee highlighted the importance of seeking inspiration from Central Forensic Laboratories (CFL) regarding their procedures. This collaborative approach aims to enhance the development of SOPs related to videography in drug regulation procedures.

Notably, the CDSCO has recently initiated efforts to establish a Digital Drugs Regulatory System (DDRS) as a unified digital ecosystem. Envisioned as a single window, single sign-on, and unified portal for all regulatory activities, DDRS aims to instill trust and confidence in the quality of drugs, medical devices, and cosmetics in both domestic and global markets.

The CDSCO has invited Expression of Interest (EoI) for the selection of a Software Services Provider (SSP) for the digital transformation of CDSCO, Indian Pharmacopoeia Commission (IPC), and National Institute of Biologicals (NIB). This digital platform is expected to revolutionize regulatory systems and ensure the production of quality medicines for India and the world.

The proposed DDRS is designed to be modular, addressing various aspects such as end-to-end management, seamless integration of stakeholders, real-time information capture, and dynamic online registries. It aims to track and trace the entire value chain, promoting better inventory management and monitoring corrective or punitive outcomes.

As the CDSCO progresses in its mission to usher in a new era of regulatory systems, the proposed DDRS stands as a testament to the commitment towards a transparent, accountable, and efficient drug regulatory environment. Stay tuned for further updates on this transformative journey in drug regulation.

<<<<<<<<<<<<<MORE NEWS>>>>>>>>>>>>>>>>

Empowering Ayurveda: CCRAS Launches ‘Ayurveda Gyan Naipunya Initiative’ (AGNI) to Elevate Evidence-Based Practices  Click  Here
CDSCO Reveals 5.5% of Drug Samples Not Meeting Standards in October 2023  Click  Here
The National Pharmacy Commission Bill 2023: A Closer Look at Education vs. Profession  Click  Here
Generic Aadhar Expands Its Noble Mission: Adds 111 New Franchise Outlets on Diwali  Click  Here
Delhi High Court Grants Eight Weeks for Central Government to Frame Policy on Online Sale of Drugs  Click  Here
Revolutionizing Pharma Safety: Proposed Revised Schedule M Guidelines to Enhance Drug Recall and Pharmacovigilance  Click  Here
Battle for Pharmacy Autonomy: AIOCD President Vigorously Opposes National Pharmacy Commission Proposal  Click  Here
Pharmacy Act Transition: Existing Educational Standards Continue Until New Benchmarks Set  Click  Here
NIPER PhD Scholars Revised Fellowship approved by Department of Pharmaceuticals  Click  Here
Redwing & Samridh Launches Groundbreaking Drone Network for Healthcare Delivery in Odisha’s Rayagada District  Click  Here
Unlocking the Sleep-Health Connection: Chronic Sleep Deficiency and Increased Insulin Resistance in Women, Especially Postmenopausal  Click  Here
National Pharmacy Commission Bill Introduces Pharmacy Advisory Council for Enhanced Regulation  Click  Here
Health Ministry Unveils Draft National Pharmacy Commission Bill 2023 – What You Need to Know Click  Here
The NPPA Sets a Price Cap on Nine Planned Formulations, one of which is a Medication for Brain Cancer Click  Here


<<<<<<<<<<<<<JOIN US>>>>>>>>>>>>>>>>

Subscribe our PHARMACY INDIA Youtube Channel for more Pharma Updates Click Here
Follow us on Instagram Click Here
Download PHARMACY INDIA MOBILE APP from Google Play Store  Click Here
Follow us on LinkedIn Click Here


Please enter your comment!
Please enter your name here